| Mar 4, 2026 |
Mar 6, 2026 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
41.3
|
-5,500
|
-2.55%
|
✓
|
$390.8K |
| Mar 2, 2026 |
Mar 4, 2026 |
Henderson Jane
|
CFO |
Sell |
46.3
|
-2,000
|
-1.09%
|
✓
|
$140.4K |
| Feb 11, 2026 |
Feb 13, 2026 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
43.8
|
-20,000
|
-1.68%
|
✓
|
$1.3M |
| Feb 4, 2026 |
Feb 4, 2026 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
41.3
|
-5,500
|
-2.54%
|
✓
|
$361.9K |
| Feb 2, 2026 |
Feb 4, 2026 |
Henderson Jane
|
CFO |
Sell |
46.3
|
-2,000
|
-1.08%
|
✓
|
$131.6K |
| Jan 22, 2026 |
Jan 22, 2026 |
Fairmount Funds Management LLC
|
Director |
Sell |
15.0
|
-1,750,000
|
-81.36%
|
✗
|
$133.5M |
| Jan 14, 2026 |
Jan 16, 2026 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
43.8
|
-20,000
|
-1.65%
|
✓
|
$1.6M |
| Jan 7, 2026 |
Jan 9, 2026 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
27.5
|
-18,700
|
-8.09%
|
✓
|
$1.5M |
| Jan 2, 2026 |
Jan 6, 2026 |
Dambkowski Carl
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Henderson Jane
|
CFO |
Sell |
37.5
|
-8,000
|
-4.14%
|
✓
|
$609.1K |
| Dec 19, 2025 |
Dec 23, 2025 |
Henderson Jane
|
CFO |
Sell |
48.8
|
-1,500
|
-0.77%
|
✓
|
$120K |
| Dec 10, 2025 |
Dec 12, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
40.0
|
-20,000
|
-1.62%
|
✓
|
$1.5M |
| Dec 4, 2025 |
Dec 5, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
35.0
|
-10,900
|
-3.87%
|
✓
|
$817.5K |
| Dec 4, 2025 |
Dec 5, 2025 |
Henderson Jane
|
CFO |
Sell |
47.5
|
-1,500
|
-0.76%
|
✓
|
$112.5K |
| Dec 4, 2025 |
Dec 5, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
32.5
|
-40,000
|
-3.14%
|
✓
|
$3M |
| Nov 25, 2025 |
Nov 28, 2025 |
Henderson Jane
|
CFO |
Sell |
47.5
|
-1,500
|
-0.76%
|
✓
|
$105K |
| Nov 14, 2025 |
Nov 14, 2025 |
Henderson Jane
|
CFO |
Sell |
45.0
|
-2,000
|
-1.00%
|
✓
|
$130K |
| Nov 11, 2025 |
Nov 13, 2025 |
Henderson Jane
|
CFO |
Sell |
48.8
|
-1,000
|
-0.50%
|
✓
|
$60K |
| Nov 13, 2025 |
Nov 13, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
40.0
|
-20,000
|
-1.55%
|
✓
|
$1.3M |
| Nov 5, 2025 |
Nov 7, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
35.0
|
-10,785
|
-3.68%
|
✓
|
$593.9K |
| Oct 10, 2025 |
Oct 15, 2025 |
Shah Nimish P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-5,110
|
-1.76%
|
✓
|
$203.4K |
| Sep 3, 2025 |
Sep 5, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-2,725
|
-1.15%
|
✓
|
$103.2K |
| Aug 6, 2025 |
Aug 8, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-2,725
|
-1.14%
|
✓
|
$103K |
| Jul 2, 2025 |
Jul 3, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
35.0
|
-10,090
|
-4.05%
|
✓
|
$455K |
| Jun 17, 2025 |
Jun 20, 2025 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Shah Nimish P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
McKenna Mark C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
JONES WILLIAM A JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Gottesdiener Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Fox Jennifer A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 20, 2025 |
Bollinger Lisa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-2,725
|
-1.11%
|
✓
|
$100.7K |
| May 7, 2025 |
May 9, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-2,725
|
-1.10%
|
✓
|
$97.4K |
| Apr 2, 2025 |
Apr 4, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-3,860
|
-1.54%
|
✓
|
$139.8K |
| Mar 5, 2025 |
Mar 7, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
51.3
|
-1,590
|
-0.63%
|
✓
|
$48.5K |
| Mar 5, 2025 |
Mar 7, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
45.0
|
-10,000
|
-0.77%
|
✓
|
$301.5K |
| Feb 5, 2025 |
Feb 7, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-3,520
|
-1.37%
|
✓
|
$143.2K |
| Feb 5, 2025 |
Feb 7, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
42.5
|
-15,000
|
-1.14%
|
✓
|
$608.7K |
| Jan 31, 2025 |
Jan 31, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2025 |
Jan 10, 2025 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
42.5
|
-15,000
|
-1.13%
|
✓
|
$732.7K |
| Jan 2, 2025 |
Jan 3, 2025 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-4,085
|
-1.57%
|
✓
|
$191.7K |
| Dec 12, 2024 |
Dec 16, 2024 |
McKenna Mark C.
|
Director |
Buy |
97.5
|
+20,000
|
100.00%
|
✗
|
$990.8K |
| Dec 11, 2024 |
Dec 13, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-4,540
|
-1.73%
|
✓
|
$221.4K |
| Dec 9, 2024 |
Dec 11, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 9, 2024 |
Dec 11, 2024 |
Henderson Jane
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 9, 2024 |
Dec 11, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 4, 2024 |
Dec 6, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
38.8
|
-6,665
|
-2.49%
|
✓
|
$307.1K |
| Dec 4, 2024 |
Dec 6, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
42.5
|
-15,000
|
-1.12%
|
✓
|
$698.7K |
| Nov 6, 2024 |
Nov 8, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
38.8
|
-6,665
|
-2.43%
|
✓
|
$394K |
| Nov 6, 2024 |
Nov 8, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
42.5
|
-15,000
|
-1.11%
|
✓
|
$888.3K |
| Oct 2, 2024 |
Oct 4, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
38.8
|
-6,665
|
-2.37%
|
✓
|
$375K |
| Oct 2, 2024 |
Oct 4, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
36.3
|
-40,000
|
-2.87%
|
✓
|
$2.2M |
| Sep 4, 2024 |
Sep 6, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
38.8
|
-6,665
|
-2.32%
|
✓
|
$317K |
| Sep 4, 2024 |
Sep 6, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
36.3
|
-40,000
|
-2.79%
|
✓
|
$1.9M |
| Aug 23, 2024 |
Aug 23, 2024 |
Henderson Jane
|
CFO |
Sell |
20.0
|
-6,000
|
-2.90%
|
✗
|
$289.6K |
| Aug 7, 2024 |
Aug 9, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
38.8
|
-7,335
|
-2.49%
|
✓
|
$298.3K |
| Aug 7, 2024 |
Aug 9, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
36.3
|
-40,000
|
-2.71%
|
✓
|
$1.6M |
| Jul 5, 2024 |
Jul 5, 2024 |
HENDERSON MICHAEL THOMAS
|
CEO |
Sell |
42.5
|
-15,000
|
-1.01%
|
✓
|
$558.9K |
| Jul 3, 2024 |
Jul 5, 2024 |
Dambkowski Carl
|
Chief Medical Officer |
Sell |
45.0
|
-5,995
|
-1.99%
|
✓
|
$225.4K |
| Jun 5, 2024 |
Jun 7, 2024 |
JONES WILLIAM A JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
McKenna Mark C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Bollinger Lisa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Fox Jennifer A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Shah Nimish P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Gottesdiener Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 28, 2024 |
May 30, 2024 |
Bollinger Lisa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 30, 2024 |
Bollinger Lisa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 28, 2024 |
Apr 1, 2024 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2024 |
Jan 31, 2024 |
Fairmount Funds Management LLC
|
Director |
Neutral |
15.0
|
-790,197
|
-88.53%
|
✓
|
- |
| Dec 18, 2023 |
Dec 20, 2023 |
Dambkowski Carl
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 18, 2023 |
Dec 20, 2023 |
Henderson Jane
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 18, 2023 |
Dec 20, 2023 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 17, 2023 |
Aug 21, 2023 |
McKenna Mark C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 21, 2023 |
McKenna Mark C.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 13, 2023 |
Jul 17, 2023 |
Gottesdiener Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 13, 2023 |
Jul 17, 2023 |
Shah Nimish P
|
Director |
Buy |
100.0
|
+1,750,000
|
100.00%
|
✗
|
$29.8M |
| Jul 13, 2023 |
Jul 17, 2023 |
Fairmount Funds Management LLC
|
Director |
Buy |
100.0
|
+2,941,176
|
100.00%
|
✗
|
$50M |
|
Jul 17, 2023 |
Dambkowski Carl
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 17, 2023 |
Henderson Jane
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 17, 2023 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 17, 2023 |
Fox Jennifer A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 17, 2023 |
JONES WILLIAM A JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Dambkowski Carl
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Henderson Jane
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
HENDERSON MICHAEL THOMAS
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Fox Jennifer A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
JONES WILLIAM A JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Gottesdiener Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Shah Nimish P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 13, 2023 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |